Quarterly Result29 Oct 2026, 05:13 pm

Bliss GVS Pharma Declares Unaudited Q2 FY27 Results

AI Summary

Bliss GVS Pharma Ltd announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The Board of Directors convened a meeting via Video Conferencing to consider and approve these results, along with the Limited Review Report from the auditors. The meeting commenced at 2:30 p.m. and concluded at 4:00 p.m.

Key Highlights

Unaudited standalone and consolidated financial results declared.
Results are for the quarter and half-year ended September 30, 2026.
Board meeting held via Video Conferencing to approve results.
Limited Review Report from auditors is enclosed.

View BSE Filing

BLISSGVS

Pharmaceuticals

BLISS GVS PHARMA LTD.

Price Impact